Trial0

Clinical trial · NCT06670820 · NOT_YET_RECRUITING · NA

iTBS in MCI and Mild AD

Sponsor: National Defense Medical Center, Taiwan

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This study aims to examine the effects of iTBS on cognitive function in individuals with MCI or mild AD, with a secondary objective of exploring prefrontal TBS mechanisms for cognitive function and the effect of iTBS on BDNF.

Interventions

  • Active rTMS · DEVICE

    iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total10 sessions

  • Sham rTMS · DEVICE

    sham iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total 10 sessions

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Clinical diagnosis of MCI (overall Clinical Dementia Rating of 0.5)
* Clinical diagnosis of mild Alzheimer's Disease (overall Clinical Dementia Rating of 0.5 or 1)

Exclusion Criteria:

* History of stroke
* History of uncontrol seizure
* History of significant head trauma followed by persistent neurologic deficit or known structural brain abnormality
* Mental illness
* Drug abuse

Sites (1)

  • Tri-Service General Hospital, Taipei, Other, Taiwan

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2024-11-01.